BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  BioLineRx Ltd. Announces Peer-Reviewed Publication Of Phase 1/2 Trial Results For Novel Treatment For Non-Surgical Removal Of Skin Lesions

  June 1, 2015

   · 

  5 min read
• Drug Development

  ASCO15: TG Therapeutics, Inc. Announces The Triple Combination Of TG-1101, TGR-1202 And Ibrutinib Is Safe And Highly Active In Patients With Advanced B-Cell Malignancies

  June 1, 2015

   · 

  9 min read
• Drug Development

  Matinas BioPharma’s MAT9001 Meets Primary And Secondary Endpoints In First Human Trial Versus Vascepa

  June 1, 2015

   · 

  6 min read
• Genetown

  ASCO15: Boston Biomedical Data At ASCO 2015 Highlights Potential Of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 And BBI503 In Multiple Cancer Types

  June 1, 2015

   · 

  9 min read
• Drug Development

  ASCO15: Novartis AG Presents New Data At ASCO For Zykadia And Combination Of Tafinlar And Mekinist In Certain NSCLC Patients With Unmet Needs

  June 1, 2015

   · 

  21 min read
• Drug Development

  Positive New, Long-Term Follow-Up Data Of Asterias Biotherapeutics’ AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival In Patients With High-Risk Acute Myelogenous Leukemia (AML)

  June 1, 2015

   · 

  9 min read
• Drug Development

  Combination Of Novartis AG Drugs Tafinlar And Mekinist Shows Significant Survival Benefit In Patients With Metastatic Melanoma

  June 1, 2015

   · 

  14 min read
• Zecotek Photonics Inc. Granted U.S. Patent For Switchable 3D/2D Optical Imaging System

  June 1, 2015

   · 

  4 min read
• Drug Development

  ASCO15: OncoMed Pharmaceuticals, Inc. Presents Data From Phase Ib Trial Of Demcizumab In Pancreatic Cancer At The 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  8 min read
• Drug Development

  ASCO15: OncoMed Pharmaceuticals, Inc. Presents Updated Demcizumab Data In Non-Small Cell Lung Cancer At The 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  8 min read